Clariance Inc

Form 483 issued June 4, 2019 · Chicago, Illinois

Inspection
May 28 – Jun 4, 2019
Observations
2
Pages
9
FEI number
3009962553

In short: On June 4, 2019, FDA issued a Form 483 with 2 observations to Clariance Inc in Chicago, Illinois (FEI 3009962553) after an inspection that ran May 28 – Jun 4, 2019. The investigators were Jesse A. Vazquez and Natasha R. Johnson. Most observations concern cAPA; the most-cited regulation is 21 CFR 806.20 (records of corrections and removals not required to be reported).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 806.20(b)(4) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    A justification for not reporting the correction or removal action to FDA that included conclusions, follow-ups…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Clariance Inc?

FDA listed 2 observations on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 806.20 (records of corrections and removals not required to be reported). The opening words of each observation are shown on this page.

Who inspected Clariance Inc?

Jesse A. Vazquez and Natasha R. Johnson are named on this Form 483, for the inspection of May 28 – Jun 4, 2019. Each investigator has a profile showing what they cite most.

When was Clariance Inc inspected by FDA?

The inspection ran May 28 – Jun 4, 2019, and the Form 483 is dated June 4, 2019.

How do I get the full Form 483 for Clariance Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free